StockData
Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp. (AVXL) stock

AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 28, 2026Score 6/30
$0.59−0.08 (-11.39%)

Close on Nov 20, 2026Market cap $54.83MP/E –Yield –

Anavex Life Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Anavex Life Sciences

Anavex Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Anavex Life Sciences figures

See a number that looks wrong?